文献速递前列腺癌

机器人辅助挽救性精囊切除术治疗低剂量率前列腺近距离放疗后孤立复发的临床与功能结局

Robot-assisted salvage seminal vesicle excision for isolated recurrence after low-dose-rate prostate brachytherapy.
PubMed 文献 · BJU Int · 2021-09-14

该研究报道了17例低剂量率前列腺近距离放疗后孤立精囊复发的患者接受机器人辅助挽救性精囊切除术(RA-SVE)的临床和功能结局。中位手术时间90分钟,出血量50毫升,无并发症,住院1天,控尿功能未受影响。术后病理均证实精囊侵犯,切缘阳性率41%。1、2、3年无失败生存率分别为86%、67%和53%。

要点

  • RA-SVE安全可行,围手术期并发症极低,不影响控尿功能。
  • 术后病理均证实精囊侵犯,切缘阳性率41%,需双侧精囊切除。
  • 1、2、3年无失败生存率分别为86%、67%、53%,部分患者可延迟ADT。

核心结论

  • 对于低剂量率前列腺近距离放疗后孤立精囊复发的患者,机器人辅助挽救性精囊切除术是一种安全的局部治疗选择,并发症率极低,可使部分患者延迟雄激素剥夺治疗。

研究设计与样本

  • 单中心回顾性研究,纳入17例低剂量率前列腺近距离放疗后生化复发、经多参数磁共振和11C-胆碱或68Ga-PSMA PET/CT及靶向穿刺活检确诊为孤立精囊复发的患者,均接受机器人辅助挽救性精囊切除术。

主要发现

  • 中位总手术时间90分钟,中位出血量50毫升,无术后输血,中位住院1天,无术中或术后并发症记录。
  • 控尿状态未受影响,无患者需要尿垫。
  • 术后病理所有标本均证实精囊侵犯,7例(41%)手术切缘阳性。
  • 所有患者至少一项影像学检查阳性,但3例(18%)mp-MRI和5例(29%)PET/CT评估为阴性;1例(6%)术前活检阴性但影像学阳性。
  • 6例患者出现挽救性精囊切除术失败(定义为连续三次PSA升高或需要进一步治疗),其中3例切缘阳性;术后1、2、3年总无失败生存率分别为86%、67%和53%。

关键数值与推荐

  • 孤立精囊复发在低剂量率前列腺近距离放疗患者中占0.38%(17例)。
  • 手术切缘阳性率为41%(7/17)。
  • 术后1年、2年、3年无失败生存率分别为86%、67%、53%。

临床怎么用

  • 对于低剂量率前列腺近距离放疗后怀疑孤立精囊复发的患者,应进行多参数磁共振和11C-胆碱或68Ga-PSMA PET/CT以及靶向穿刺活检以明确诊断。
  • 机器人辅助挽救性精囊切除术可作为 selected 患者的局部治疗选择,以延迟雄激素剥夺治疗,手术须行双侧精囊切除。

局限性

  • 样本量小(17例),为单中心回顾性研究,随访时间有限,结论需更大样本和更长随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report clinical and functional outcomes for patients who have undergone salvage robot-assisted seminal vesicle excision (RA-SVE) for the focal treatment of isolated seminal vesical (SV) recurrence after treatment for prostate cancer by low-dose-rate brachytherapy. PATIENTS AND METHODS: Patients with rising prostate-specific antigen (PSA) after low-dose-rate prostate brachytherapy (LDR-PB) underwent multi-parametric magnetic resonance imaging (mp-MRI) of the prostate and 11 C-Choline or 68 Ga-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography/computed tomography (PET/CT) scan, followed by targeted transperineal biopsy of the prostate and SVs. Isolated SV recurrence were identified in 17 (0.38%) LDR-PB patients. These 17 patients were offered RA-SVE. RESULTS: The median total operative time was 90 min and blood loss 50 mL with no postoperative transfusions required. The median hospital stay was 1 day. No intra- or postoperative complications were documented. Continence status was unaffected, no patient required urinary pads. Postoperative pathology confirmed SV invasion in all specimens. Surgical margins were positive in seven (41%) patients. All patients had at least one positive imaging study, although three (18%) mp-MRI and five (29%) PET/CT assessments were negative. One (6%) pre-SVE biopsy was also negative but with positive imaging. Salvage SVE failure, defined as three consecutive PSA rises or the need for further treatment, occurred in six patients of whom three had a positive margin. Overall failure-free survival rates were 86%, 67%, and 53% at 1, 2, and 3 years after SVE, respectively. CONCLUSIONS: Salvage RA-SVE appears to be a safe focal treatment, with very low morbidity, for patients with localised SV recurrence after LDR-PB. It permits deferral of androgen deprivation therapy in selected patients. Bilateral SVE is mandatory. This surgical option should be considered in patients with isolated prostate cancer recurrence to the SV.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Langley S, Eden C, Perry M, et al. Robot-assisted salvage seminal vesicle excision for isolated recurrence after low-dose-rate prostate brachytherapy. BJU Int. 2021. PMID: 34460980. doi:10.1111/bju.15586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。